|
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).
Extrawell Pharmaceutical Holdings Limited (精优药业控股有限公司)
Main Activities: Chemical Manufacturing
 |
Please check the full coverage of information what EMIS can offer you. | SEE SAMPLE |
Company Information |
|
Full name Extrawell Pharmaceutical Holdings Limited (精优药业控股有限公司) Headquarters Rooms 3409-10, 34th Floor, China Resources Building, 26 Harbour Road, Wanchai, Hong Kong; Hong Kong; Hong Kong |
Status: Listed Legal Form: Public Limited Company Operational Status: Operational ISIN CODE : BMG3285Q1134 Financial Auditors: East Asia Sentinel Limited (2013) Incorporation Date: December 8, 1998 Total Employees: 290 Tel: (852) 2856-1918 |
|
Company Description |
| The principal activities are the marketing and distribution of pharmaceutical products to customers in the People＇s Republic of China (the ‘PRC＇); the development, manufacture and sales of pharmaceutical products in the PRC; the business of commercial exploitation and development of genome-related technology; and the development and commercialisation of oral insulin products. |
Key Executives |
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
FULL COMPANY PROFILE
|
|
2012 Y (cons) |
2012 H1 (cons) |
|
 | ||
| Audited | Audited | |
| ||
| Unit | 1 | 1 |
| ||
Balance Sheet
| ||
Total Assets |
XXX |
XXX |
| ||
Current Assets |
XXX |
XXX |
| ||
Total Liabilities |
XXX |
XXX |
| ||
Shareholders Equity |
XXX |
XXX |
| ||
Current Liabilities |
XXX |
XXX |
| ||
| * All the accounts are in HKD. | ||
Income Statement
| ||
Total Operating Revenue |
XXX |
XXX |
| ||
Operational Profit (Loss) |
XXX |
XXX |
| ||
Net Profit (Loss) |
XXX |
XXX |
| ||
| * All the accounts are in HKD. | ||
Ratios
| Profitability Ratios | ||
| ||
Return on Assets (ROA) |
XXX |
XXX |
| ||
Annualised Return on Assets (ROA) |
XXX |
XXX |
| ||
Return on Equity (ROE) |
XXX |
XXX |
| ||
Annualised Return on Equity (ROE) |
XXX |
XXX |
| ||
Return on Sales (ROS) |
XXX |
XXX |
| ||
Return on Capital |
XXX |
XXX |
| ||
Gross Profit Margin |
XXX |
XXX |
| ||
Operating Profit Margin |
XXX |
XXX |
| Efficiency Ratios | ||
| ||
Accounts Receivable Turnover |
XXX |
XXX |
| ||
Inventory Turnover |
XXX |
XXX |
| ||
Current asset turnover |
XXX |
XXX |
| ||
Fixed-asset turnover |
XXX |
XXX |
| ||
Asset Turnover |
XXX |
XXX |
| Valuation figures and ratios | ||
| ||
Earning Before Interests and Taxes (EBIT) |
XXX |
XXX |
| ||
EBITDA |
XXX |
XXX |
| ||
Enterprise value |
XXX |
XXX |
| ||
Enterprise Value / EBITDA |
XXX |
XXX |
| ||
Bookvalue (BV) |
XXX |
XXX |
| Liquidity Ratios | ||
| ||
Current Ratio |
XXX |
XXX |
| ||
Quick ratio |
XXX |
XXX |
| ||
Doom's day ratio |
XXX |
XXX |
| Leverage Ratios | ||
| ||
Leverage ratio |
XXX |
XXX |
| Market ratios | ||
| ||
Price/Book Ratio |
XXX |
XXX |
| Trend Ratios | ||
| ||
Revenue Trend |
XXX |
XXX |
| ||
Net Income Trend |
XXX |
XXX |
| ||
Operating Income Trend |
XXX |
XXX |
| ||
 |